Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06722183 |
Title | A Phase II Platform Trial of Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities (FUTURE) |
Acronym | FUTURE |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | DEU |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Klinikum St. Marien Amberg | Amberg | Germany | Details | |||
Charité Campus Virchow Klinikum (CVK) | Berlin | Germany | Details | |||
Universitätsklinikum Düsseldorf | Düsseldorf | Germany | Details | |||
Kliniken Essen-Mitte | Essen | Germany | Details | |||
Krankenhaus Nordwest | Frankfurt am Main | 60488 | Germany | Details | ||
Hope Hamburg | Hamburg | Germany | Details | |||
Universitätsmedizin Mainz | Mainz | Germany | Details | |||
Klinikum München rechts der Isar | München | Germany | Details | |||
MVZ für Hämatologie und Onkologie Ravensburg GmbH | Ravensburg | 88212 | Germany | Details | ||
Leopoldina Krankenhaus Schweinfurt | Schweinfurt | Germany | Details | |||
Universitätsklinikum Ulm | Ulm | Germany | Details |